Baydoun, Atallah http://orcid.org/0000-0003-0244-5583
Jia, Angela Y. http://orcid.org/0000-0002-0812-2614
Zaorsky, Nicholas G.
Kashani, Rojano
Rao, Santosh
Shoag, Jonathan E.
Vince, Randy A. Jr
Bittencourt, Leonardo Kayat http://orcid.org/0000-0001-9175-9626
Zuhour, Raed http://orcid.org/0000-0001-5537-6644
Price, Alex T.
Arsenault, Theodore H.
Spratt, Daniel E. http://orcid.org/0000-0002-5973-4741
Article History
Received: 25 March 2023
Revised: 5 May 2023
Accepted: 30 May 2023
First Online: 9 June 2023
Competing interests
: AB: None. AYJ: Personal Fees from Myovant. NGZ: Support by the National Institutes of Health Grant LRP 1 L30 CA231572-01 (2018-2022) and by the American Cancer Society – Tri State CEOs Against Cancer Clinician Scientist Development Grant, CSDG-20-013-01-CCE (2020-). Remuneration from Springer Nature for his textbook, Absolute Clinical Radiation Oncology Review (2019). Remuneration from the American College of Radiation Oncology for chart review and accreditation of radiation oncology facilities nationally (2020-). RK: None. SR: Personal speaking fees from Seagen. JS: Grant support from BMS Foundation, Damon Runyon Cancer Research Foundation. Key opinon leader for Fortec Medical. RAV: None. LKB: None. RZ: None. AP: Honoraria with both ViewRay and SunNuclear. THA: None. DES: Personal fees from AstraZeneca, Blue Earth, Bayer, Boston Scientific, Janssen, Novartis, Myovant, Pfizer, Varian, Elekta, Gamma Tile.